| Year |
Citation |
Score |
| 2020 |
Makhaeva GF, Kovaleva NV, Boltneva NP, Lushchekina SV, Astakhova TY, Rudakova EV, Proshin AN, Serkov IV, Radchenko EV, Palyulin VA, Bachurin SO, Richardson RJ. New Hybrids of 4-Amino-2,3-polymethylene-quinoline and -Tolylsulfonamide as Dual Inhibitors of Acetyl- and Butyrylcholinesterase and Potential Multifunctional Agents for Alzheimer's Disease Treatment. Molecules (Basel, Switzerland). 25. PMID 32867324 DOI: 10.3390/Molecules25173915 |
0.375 |
|
| 2020 |
Talley TT, Chao CK, Berkman CE, Richardson RJ, Thompson CM. Inhibition of acetylcholinesterases by stereoisomeric organophosphorus compounds containing both thioester and p-nitrophenyl leaving groups. Chemical Research in Toxicology. PMID 32833441 DOI: 10.1021/Acs.Chemrestox.0C00236 |
0.423 |
|
| 2020 |
Richardson RJ, Fink JK, Glynn P, Hufnagel RB, Makhaeva GF, Wijeyesakere SJ. Neuropathy target esterase (NTE/PNPLA6) and organophosphorus compound-induced delayed neurotoxicity (OPIDN). Advances in Neurotoxicology. 4: 1-78. PMID 32518884 DOI: 10.1016/bs.ant.2020.01.001 |
0.731 |
|
| 2019 |
Makhaeva GF, Kovaleva NV, Boltneva NP, Lushchekina SV, Rudakova EV, Stupina TS, Terentiev AA, Serkov IV, Proshin AN, Radchenko EV, Palyulin VV, Bachurin SO, Richardson RJ. Conjugates of tacrine and 1,2,4-thiadiazole derivatives as new potential multifunctional agents for Alzheimer's disease treatment: Synthesis, quantum-chemical characterization, molecular docking, and biological evaluation. Bioorganic Chemistry. 103387. PMID 31735356 DOI: 10.1016/J.Bioorg.2019.103387 |
0.359 |
|
| 2019 |
Khudina OG, Makhaeva GF, Elkina NA, Boltneva NP, Serebryakova OG, Shchegolkov EV, Rudakova EV, Lushchekina SV, Burgart YV, Bachurin SO, Richardson RJ, Saloutin VI. Synthesis of 2-arylhydrazinylidene-3-oxo-4,4,4-trifluorobutanoic acids as new selective carboxylesterase inhibitors and radical scavengers. Bioorganic & Medicinal Chemistry Letters. 126716. PMID 31640885 DOI: 10.1016/J.Bmcl.2019.126716 |
0.309 |
|
| 2019 |
Makhaeva GF, Elkina NA, Shchegolkov EV, Boltneva NP, Lushchekina SV, Serebryakova OG, Rudakova EV, Kovaleva NV, Radchenko EV, Palyulin VA, Burgart YV, Saloutin VI, Bachurin SO, Richardson RJ. Synthesis, molecular docking, and biological evaluation of 3-oxo-2-tolylhydrazinylidene-4,4,4-trifluorobutanoates bearing higher and natural alcohol moieties as new selective carboxylesterase inhibitors. Bioorganic Chemistry. 91: 103097. PMID 31323527 DOI: 10.1016/J.Bioorg.2019.103097 |
0.369 |
|
| 2019 |
Makhaeva GF, Shevtsova EF, Boltneva NP, Lushchekina SV, Kovaleva NV, Rudakova EV, Bachurin SO, Richardson RJ. Overview of novel multifunctional agents based on conjugates of γ-carbolines, carbazoles, tetrahydrocarbazoles, phenothiazines, and aminoadamantanes for treatment of Alzheimer's disease. Chemico-Biological Interactions. PMID 31100279 DOI: 10.1016/J.Cbi.2019.05.020 |
0.342 |
|
| 2019 |
Bachurin SO, Makhaeva GF, Shevtsova EF, Boltneva NP, Kovaleva NV, Lushchekina SV, Rudakova EV, Dubova LG, Vinogradova DV, Sokolov VB, Aksinenko AY, Fisenko VP, Richardson RJ, Aliev G. Conjugates of methylene blue with γ-carboline derivatives as new multifunctional agents for the treatment of neurodegenerative diseases. Scientific Reports. 9: 4873. PMID 30890752 DOI: 10.1038/S41598-019-41272-4 |
0.341 |
|
| 2018 |
Makhaeva GF, Boltneva NP, Lushchekina SV, Rudakova EV, Serebryakova OG, Kulikova LN, Beloglazkin AA, Borisov RS, Richardson RJ. Synthesis, molecular docking, and biological activity of 2-vinyl chromones: Toward selective butyrylcholinesterase inhibitors for potential Alzheimer's disease therapeutics. Bioorganic & Medicinal Chemistry. PMID 30104121 DOI: 10.1016/J.Bmc.2018.08.010 |
0.376 |
|
| 2017 |
Makhaeva GF, Lushchekina SV, Boltneva NP, Serebryakova OG, Rudakova EV, Ustyugov AA, Bachurin SO, Shchepochkin AV, Chupakhin ON, Charushin VN, Richardson RJ. 9-Substituted acridine derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors possessing antioxidant activity for Alzheimer's disease treatment. Bioorganic & Medicinal Chemistry. PMID 28986116 DOI: 10.1016/J.Bmc.2017.09.028 |
0.376 |
|
| 2017 |
Shchegol'kov EV, Makhaeva GF, Boltneva NP, Lushchekina SV, Serebryakova OG, Rudakova EV, Kovaleva NV, Burgart YV, Saloutin VI, Chupakhin ON, Bachurin SO, Richardson RJ. Synthesis, molecular docking, and biological activity of polyfluoroalkyl dihydroazolo[5,1-c][1,2,4]triazines as selective carboxylesterase inhibitors. Bioorganic & Medicinal Chemistry. PMID 28578994 DOI: 10.1016/J.Bmc.2017.05.045 |
0.363 |
|
| 2016 |
Makhaeva GF, Rudakova EV, Serebryakova OG, Aksinenko AY, Lushchekina SV, Bachurin SO, Richardson RJ. Esterase profiles of organophosphorus compounds in vitro predict their behavior in vivo. Chemico-Biological Interactions. PMID 27154493 DOI: 10.1016/J.Cbi.2016.05.002 |
0.397 |
|
| 2016 |
Makhaeva GF, Rudakova EV, Sigolaeva LV, Kurochkin IN, Richardson RJ. Neuropathy target esterase in mouse whole blood as a biomarker of exposure to neuropathic organophosphorus compounds. Journal of Applied Toxicology : Jat. PMID 26970094 DOI: 10.1002/Jat.3305 |
0.386 |
|
| 2016 |
Makhaeva GF, Boltneva NP, Lushchekina SV, Serebryakova OG, Stupina TS, Terentiev AA, Serkov IV, Proshin AN, Bachurin SO, Richardson RJ. Synthesis, molecular docking and biological evaluation of N,N-disubstituted 2-aminothiazolines as a new class of butyrylcholinesterase and carboxylesterase inhibitors. Bioorganic & Medicinal Chemistry. 24: 1050-62. PMID 26827140 DOI: 10.1016/J.Bmc.2016.01.031 |
0.386 |
|
| 2015 |
Hufnagel RB, Arno G, Hein ND, Hersheson J, Prasad M, Anderson Y, Krueger LA, Gregory LC, Stoetzel C, Jaworek TJ, Hull S, Li A, Plagnol V, Willen CM, Morgan TM, ... ... Richardson RJ, et al. Neuropathy target esterase impairments cause Oliver-McFarlane and Laurence-Moon syndromes. Journal of Medical Genetics. 52: 85-94. PMID 25480986 DOI: 10.1136/Jmedgenet-2014-102856 |
0.747 |
|
| 2015 |
Richardson RJ, Mark Worden R, Wijeyesakere SJ, Hein ND, Fink JK, Makhaeva GF. Neuropathy Target Esterase as a Biomarker and Biosensor of Delayed Neuropathic Agents Handbook of Toxicology of Chemical Warfare Agents: Second Edition. 935-952. DOI: 10.1016/B978-0-12-800159-2.00063-4 |
0.768 |
|
| 2015 |
Makhaeva GF, Rudakova EV, Serebryakova OG, Aksinenko AY, Richardson RJ, Bachurin SO. Esterase profiles of hexafluoropropan-2-ol-based dialkyl phosphates as a major determinant of their effects in mouse brain in vivo Russian Chemical Bulletin. 64: 2203-2209. DOI: 10.1007/S11172-015-1139-4 |
0.342 |
|
| 2014 |
Wijeyesakere SJ, Richardson RJ, Stuckey JA. Crystal structure of patatin-17 in complex with aged and non-aged organophosphorus compounds. Plos One. 9: e108245. PMID 25248161 DOI: 10.1371/Journal.Pone.0108245 |
0.754 |
|
| 2014 |
Brott DA, Katein A, Thomas H, Lawton M, Montgomery RR, Richardson RJ, Louden CS. Evaluation of von Willebrand factor and von Willebrand factor propeptide in models of vascular endothelial cell activation, perturbation, and/or injury. Toxicologic Pathology. 42: 672-83. PMID 24499802 DOI: 10.1177/0192623313518664 |
0.676 |
|
| 2014 |
Makhaeva GF, Rudakova EV, Hein ND, Serebryakova OG, Kovaleva NV, Boltneva NP, Fink JK, Richardson RJ. Further studies toward a mouse model for biochemical assessment of neuropathic potential of organophosphorus compounds. Journal of Applied Toxicology : Jat. 34: 1426-35. PMID 24395470 DOI: 10.1002/Jat.2977 |
0.788 |
|
| 2013 |
Makhaeva GF, Lushchekina SV, Serebryakova OG, Aksinenko AY, Goreva TV, Richardson RJ, Martynov IV. Kinetics and mechanism of inhibition of serine esterases by fluorinated carbethoxy 1-aminophosphonates. Doklady. Biochemistry and Biophysics. 451: 203-6. PMID 23975401 DOI: 10.1134/S1607672913040091 |
0.318 |
|
| 2013 |
Richardson RJ, Hein ND, Wijeyesakere SJ, Fink JK, Makhaeva GF. Neuropathy target esterase (NTE): overview and future. Chemico-Biological Interactions. 203: 238-44. PMID 23220002 DOI: 10.1016/J.Cbi.2012.10.024 |
0.768 |
|
| 2013 |
Makhaeva GF, Radchenko EV, Palyulin VA, Rudakova EV, Aksinenko AY, Sokolov VB, Zefirov NS, Richardson RJ. Organophosphorus compound esterase profiles as predictors of therapeutic and toxic effects. Chemico-Biological Interactions. 203: 231-7. PMID 23123251 DOI: 10.1016/J.Cbi.2012.10.012 |
0.393 |
|
| 2013 |
Sigolaeva LV, Dubacheva GV, Porus MV, Eremenko AV, Rudakova EV, Makhaeva GF, Richardson RJ, Kurochkin IN. A layer-by-layer tyrosinase biosensor for assay of carboxylesterase and neuropathy target esterase activities in blood Analytical Methods. 5: 3872. DOI: 10.1039/C3Ay40339D |
0.314 |
|
| 2012 |
Makhaeva GF, Radchenko EV, Baskin II, Palyulin VA, Richardson RJ, Zefirov NS. Combined QSAR studies of inhibitor properties of O-phosphorylated oximes toward serine esterases involved in neurotoxicity, drug metabolism and Alzheimer's disease. Sar and Qsar in Environmental Research. 23: 627-47. PMID 22587543 DOI: 10.1080/1062936X.2012.679690 |
0.368 |
|
| 2012 |
Rudakova EV, Makhaeva GF, Galenko TG, Aksinenko AY, Sokolov VB, Richardson RJ, Martynov IV. Esterase profile of O-phosphorylated ethyltrifluorolactates in prediction of their therapeutic and toxic effects. Doklady. Biochemistry and Biophysics. 443: 81-5. PMID 22562631 DOI: 10.1134/S1607672912020068 |
0.385 |
|
| 2012 |
Brott DA, Richardson RJ, Louden CS. Evidence for the nitric oxide pathway as a potential mode of action in fenoldopam-induced vascular injury. Toxicologic Pathology. 40: 874-86. PMID 22549976 DOI: 10.1177/0192623312444027 |
0.673 |
|
| 2012 |
Wang Y, Liu X, Schneider B, Zverina EA, Russ K, Wijeyesakere SJ, Fierke CA, Richardson RJ, Philbert MA. Mixed inhibition of adenosine deaminase activity by 1,3-dinitrobenzene: a model for understanding cell-selective neurotoxicity in chemically-induced energy deprivation syndromes in brain. Toxicological Sciences : An Official Journal of the Society of Toxicology. 125: 509-21. PMID 22106038 DOI: 10.1093/Toxsci/Kfr317 |
0.748 |
|
| 2010 |
Hein ND, Rainier SR, Richardson RJ, Fink JK. Motor neuron disease due to neuropathy target esterase mutation: enzyme analysis of fibroblasts from human subjects yields insights into pathogenesis. Toxicology Letters. 199: 1-5. PMID 20603202 DOI: 10.1016/J.Toxlet.2010.06.020 |
0.767 |
|
| 2010 |
Hein ND, Stuckey JA, Rainier SR, Fink JK, Richardson RJ. Constructs of human neuropathy target esterase catalytic domain containing mutations related to motor neuron disease have altered enzymatic properties. Toxicology Letters. 196: 67-73. PMID 20382209 DOI: 10.1016/J.Toxlet.2010.03.1120 |
0.784 |
|
| 2010 |
Sigolaeva L, Makhaeva G, Rudakova E, Boltneva N, Porus M, Dubacheva G, Eremenko A, Kurochkin I, Richardson RJ. Biosensor analysis of blood esterases for organophosphorus compounds exposure assessment: approaches to simultaneous determination of several esterases. Chemico-Biological Interactions. 187: 312-7. PMID 20097186 DOI: 10.1016/J.Cbi.2010.01.028 |
0.306 |
|
| 2010 |
Makhaeva GF, Aksinenko AY, Sokolov VB, Baskin II, Palyulin VA, Zefirov NS, Hein ND, Kampf JW, Wijeyesakere SJ, Richardson RJ. Kinetics and mechanism of inhibition of serine esterases by fluorinated aminophosphonates. Chemico-Biological Interactions. 187: 177-84. PMID 20035729 DOI: 10.1016/J.Cbi.2009.12.018 |
0.76 |
|
| 2010 |
Wijeyesakere SJ, Richardson RJ. Neuropathy Target Esterase Hayes' Handbook of Pesticide Toxicology. 1435-1455. DOI: 10.1016/B978-0-12-374367-1.00067-7 |
0.747 |
|
| 2009 |
Makhaeva GF, Aksinenko AY, Sokolov VB, Serebryakova OG, Richardson RJ. Synthesis of organophosphates with fluorine-containing leaving groups as serine esterase inhibitors with potential for Alzheimer disease therapeutics. Bioorganic & Medicinal Chemistry Letters. 19: 5528-30. PMID 19717305 DOI: 10.1016/J.Bmcl.2009.08.065 |
0.311 |
|
| 2008 |
Wijeyesakere SJ, Nasser FA, Kampf JW, Aksinenko AY, Sokolov VB, Malygin VV, Makhaeva GF, Richardson RJ. Diethyl [2,2,2-trifluoro-1-phenyl-sulfonyl-amino-1-(trifluoro-meth-yl)eth-yl]phospho-nate. Acta Crystallographica. Section E, Structure Reports Online. 64: o1425. PMID 19079747 DOI: 10.1107/S1600536808020175 |
0.693 |
|
| 2008 |
Rainier S, Bui M, Mark E, Thomas D, Tokarz D, Ming L, Delaney C, Richardson RJ, Albers JW, Matsunami N, Stevens J, Coon H, Leppert M, Fink JK. Neuropathy target esterase gene mutations cause motor neuron disease. American Journal of Human Genetics. 82: 780-5. PMID 18313024 DOI: 10.1016/J.Ajhg.2007.12.018 |
0.342 |
|
| 2008 |
Brott D, Gould S, Jones H, Schofield J, Prior H, Valentin JP, Bjurstrom S, Kenne K, Schuppe-Koistinen I, Katein A, Foster-Brown L, Betton G, Richardson R, Evans G, Louden C. Biomarkers of drug-induced vascular injury. Toxicology and Applied Pharmacology. 207: 441-5. PMID 15982681 DOI: 10.1016/J.Taap.2005.04.028 |
0.669 |
|
| 2007 |
Makhaeva GF, Malygin VV, Strakhova NN, Sigolaeva LV, Sokolovskaya LG, Eremenko AV, Kurochkin IN, Richardson RJ. Biosensor assay of neuropathy target esterase in whole blood as a new approach to OPIDN risk assessment: review of progress. Human & Experimental Toxicology. 26: 273-82. PMID 17615108 DOI: 10.1177/0960327106070463 |
0.308 |
|
| 2007 |
Kohli N, Srivastava D, Sun J, Richardson RJ, Lee I, Worden RM. Nanostructured biosensor for measuring neuropathy target esterase activity. Analytical Chemistry. 79: 5196-203. PMID 17555296 DOI: 10.1021/Ac0701684 |
0.354 |
|
| 2007 |
Kropp TJ, Richardson RJ. Mechanism of aging of mipafox-inhibited butyrylcholinesterase. Chemical Research in Toxicology. 20: 504-10. PMID 17323978 DOI: 10.1021/Tx600310Y |
0.795 |
|
| 2007 |
Wijeyesakere SJ, Richardson RJ, Stuckey JA. Modeling the tertiary structure of the patatin domain of neuropathy target esterase. The Protein Journal. 26: 165-72. PMID 17216363 DOI: 10.1007/S10930-006-9058-8 |
0.726 |
|
| 2006 |
Louden C, Brott D, Katein A, Kelly T, Gould S, Jones H, Betton G, Valetin JP, Richardson RJ. Biomarkers and mechanisms of drug-induced vascular injury in non-rodents. Toxicologic Pathology. 34: 19-26. PMID 16507540 DOI: 10.1080/01926230500512076 |
0.672 |
|
| 2006 |
Kropp TJ, Richardson RJ. Aging of mipafox-inhibited human acetylcholinesterase proceeds by displacement of both isopropylamine groups to yield a phosphate adduct. Chemical Research in Toxicology. 19: 334-9. PMID 16485911 DOI: 10.1021/Tx050342O |
0.791 |
|
| 2005 |
Brott DA, Jones HB, Gould S, Valentin JP, Evans G, Richardson RJ, Louden C. Current status and future directions for diagnostic markers of drug-induced vascular injury. Cancer Biomarkers : Section a of Disease Markers. 1: 15-28. PMID 17192029 DOI: 10.3233/Cbm-2005-1104 |
0.667 |
|
| 2005 |
Sokolovskaya LG, Sigolaeva LV, Eremenko AV, Gachok IV, Makhaeva GF, Strakhova NN, Malygin VV, Richardson RJ, Kurochkin IN. Improved electrochemical analysis of neuropathy target esterase activity by a tyrosinase carbon paste electrode modified by 1-methoxyphenazine methosulfate. Biotechnology Letters. 27: 1211-8. PMID 16158266 DOI: 10.1007/S10529-005-0020-1 |
0.365 |
|
| 2004 |
Kropp TJ, Glynn P, Richardson RJ. The mipafox-inhibited catalytic domain of human neuropathy target esterase ages by reversible proton loss. Biochemistry. 43: 3716-22. PMID 15035642 DOI: 10.1021/Bi049960E |
0.778 |
|
| 2003 |
Doorn JA, Thompson CM, Christner RB, Richardson RJ. Stereoselective inactivation of Torpedo californica acetylcholinesterase by isomalathion: inhibitory reactions with (1R)- and (1S)-isomers proceed by different mechanisms. Chemical Research in Toxicology. 16: 958-65. PMID 12924923 DOI: 10.1021/Tx030026E |
0.671 |
|
| 2003 |
Kropp TJ, Richardson RJ. Relative inhibitory potencies of chlorpyrifos oxon, chlorpyrifos methyl oxon, and mipafox for acetylcholinesterase versus neuropathy target esterase. Journal of Toxicology and Environmental Health. Part A. 66: 1145-57. PMID 12791540 DOI: 10.1080/15287390306360 |
0.788 |
|
| 2003 |
Malygin VV, Sokolov VB, Richardson RJ, Makhaeva GF. Quantitative structure-activity relationships predict the delayed neurotoxicity potential of a series of O-alkyl-O-methylchloroformimino phenylphosphonates. Journal of Toxicology and Environmental Health. Part A. 66: 611-25. PMID 12746136 DOI: 10.1080/15287390309353770 |
0.401 |
|
| 2003 |
Makhaeva GF, Sigolaeva LV, Zhuravleva LV, Eremenko AV, Kurochkin IN, Malygin VV, Richardson RJ. Biosensor detection of neuropathy target esterase in whole blood as a biomarker of exposure to neuropathic organophosphorus compounds. Journal of Toxicology and Environmental Health. Part A. 66: 599-610. PMID 12746135 DOI: 10.1080/15287390309353769 |
0.378 |
|
| 2003 |
Brott DA, Maher RJ, Parrish CR, Richardson RJ, Smith AK. Flow cytometric characterization of perfused human bone marrow cultures: identification of the major cell lineages and correlation with the CFU-GM assay. Cytometry. Part a : the Journal of the International Society For Analytical Cytology. 53: 22-7. PMID 12701129 DOI: 10.1002/cyto.a.10034 |
0.62 |
|
| 2001 |
Doorn JA, Schall M, Gage DA, Talley TT, Thompson CM, Richardson RJ. Identification of butyrylcholinesterase adducts after inhibition with isomalathion using mass spectrometry: difference in mechanism between (1R)- and (1S)-stereoisomers. Toxicology and Applied Pharmacology. 176: 73-80. PMID 11601883 DOI: 10.1006/Taap.2001.9279 |
0.678 |
|
| 2001 |
Doorn JA, Talley TT, Thompson CM, Richardson RJ. Probing the active sites of butyrylcholinesterase and cholesterol esterase with isomalathion: conserved stereoselective inactivation of serine hydrolases structurally related to acetylcholinesterase. Chemical Research in Toxicology. 14: 807-13. PMID 11453726 DOI: 10.1021/Tx015501S |
0.665 |
|
| 2000 |
Doorn JA, Gage DA, Schall M, Talley TT, Thompson CM, Richardson RJ. Inhibition of acetylcholinesterase by (1S,3S)-isomalathion proceeds with loss of thiomethyl: kinetic and mass spectral evidence for an unexpected primary leaving group. Chemical Research in Toxicology. 13: 1313-20. PMID 11123973 DOI: 10.1021/Tx000184V |
0.685 |
|
| 1999 |
Jianmongkol S, Marable BR, Berkman CE, Talley TT, Thompson CM, Richardson RJ. Kinetic evidence for different mechanisms of acetylcholinesterase inhibition by (1R)- and (1S)-stereoisomers of isomalathion. Toxicology and Applied Pharmacology. 155: 43-53. PMID 10036217 DOI: 10.1006/Taap.1998.8608 |
0.769 |
|
| 1997 |
Randall JC, Ambroso JL, Groutas WC, Brubaker MJ, Richardson RJ. Inhibition of neurotoxic esterase in vitro by novel carbamates Toxicology and Applied Pharmacology. 143: 173-178. PMID 9073605 DOI: 10.1006/Taap.1996.8082 |
0.341 |
|
| 1996 |
Jianmongkol S, Berkman CE, Thompson CM, Richardson RJ. Relative potencies of the four stereoisomers of isomalathion for inhibition of hen brain acetylcholinesterase and neurotoxic esterase in vitro. Toxicology and Applied Pharmacology. 139: 342-8. PMID 8806851 DOI: 10.1006/Taap.1996.0174 |
0.722 |
|
| 1995 |
Richardson RJ. Assessment of the neurotoxic potential of chlorpyrifos relative to other organophosphorus compounds: A critical review of the literature Journal of Toxicology and Environmental Health. 44: 135-164. PMID 7531775 DOI: 10.1080/15287399509531952 |
0.365 |
|
| 1993 |
Richardson RJ, Moore TB, Kayyali US, Randall JC. Chlorpyrifos: Assessment of Potential for Delayed Neurotoxicity by Repeated Dosing in Adult Hens with Monitoring of Brain Acetylcholinesterase, Brain and Lymphocyte Neurotoxic Esterase, and Plasma Butyrylcholinesterase Activities Fundamental and Applied Toxicology. 21: 89-96. PMID 7689993 DOI: 10.1006/Faat.1993.1076 |
0.307 |
|
| 1993 |
Richardson RJ, Moore TB, Kayyali US, Fowke JH, Randall JC. Inhibition of hen brain acetylcholinesterase and neurotoxic esterase by chlorpyrifos in Vivo and kinetics of inhibition by chlorpyrifos oxon in Vitro: Application to assessment of neuropathic risk Toxicological Sciences. 20: 273-279. DOI: 10.1006/Faat.1993.1036 |
0.383 |
|
| 1991 |
Kayyali US, Moore TB, Randall JC, Richardson RJ. Neurotoxic esterase (NTE) assay: Optimized conditions based on detergent-induced shifts in the phenol/4-aminoantipyrine chromophore spectrum Journal of Analytical Toxicology. 15: 86-89. PMID 2051750 DOI: 10.1093/Jat/15.2.86 |
0.305 |
|
| 1988 |
Robertson DG, Mattson AM, Bestervelt LL, Richardson RJ, Anderson RJ. Time course of electrophysiologic effects induced by di-n-butyl-2,2-dichlorovinyl phosphate (DBCV) in the adult hen. Journal of Toxicology and Environmental Health. 23: 283-94. PMID 3351976 DOI: 10.1080/15287398809531114 |
0.311 |
|
| 1987 |
Reiner E, Davis CS, Schwab BW, Schopfer LM, Richardson RJ. Kinetics of heat inactivation of phenyl valerate hydrolases from hen and rat brain Biochemical Pharmacology. 36: 3181-3185. PMID 3663234 DOI: 10.1016/0006-2952(87)90630-7 |
0.302 |
|
| 1987 |
Davis CS, Richardson RJ. Neurotoxic esterase: Characterization of the solubilized enzyme and the conditions for its solubilization from chicken brain microsomal membranes with ionic, zwitterionic, or nonionic detergents Biochemical Pharmacology. 36: 1393-1399. PMID 3579980 DOI: 10.1016/0006-2952(87)90104-3 |
0.31 |
|
| 1986 |
Schwab BW, Richardson RJ. Lymphocyte and brain neurotoxic esterase: Dose and time dependence of inhibition in the hen examined with three organophosphorus esters Toxicology and Applied Pharmacology. 83: 1-9. PMID 3952739 DOI: 10.1016/0041-008X(86)90317-0 |
0.368 |
|
| 1982 |
Dudek BR, Richardson RJ. Evidence for the existence of neurotoxic esterase in neural and lymphatic tissue of the adult hen Biochemical Pharmacology. 31: 1117-1121. PMID 7082366 DOI: 10.1016/0006-2952(82)90351-3 |
0.309 |
|
| 1979 |
Richardson RJ, Davis CS, Johnson MK. Subcellular distribution of marker enzymes and of neurotoxic esterase in adult hen brain Journal of Neurochemistry. 32: 607-615. PMID 216779 DOI: 10.1111/J.1471-4159.1979.Tb00391.X |
0.535 |
|
| 1977 |
Richardson RJ, Wilder AC, Murphy SD. Maintenance of glutathione levels in renal cortex slices of the rat. Proceedings of the Society For Experimental Biology and Medicine. Society For Experimental Biology and Medicine (New York, N.Y.). 154: 360-4. PMID 846995 DOI: 10.3181/00379727-154-39671 |
0.461 |
|
| 1975 |
Richardson RJ, Wilder AC, Murphy SD. Uptake of mercury and mercury-amino acid complexes by rat renal cortex slices. Proceedings of the Society For Experimental Biology and Medicine. Society For Experimental Biology and Medicine (New York, N.Y.). 150: 303-7. PMID 1208541 DOI: 10.3181/00379727-150-39024 |
0.483 |
|
| 1975 |
Richardson RJ, Murphy SD. Effect of glutathione depletion on tissue deposition of methylmercury in rats Toxicology and Applied Pharmacology. 31: 505-519. PMID 1145635 DOI: 10.1016/0041-008X(75)90274-4 |
0.547 |
|
| 1974 |
Richardson RJ, Murphy SD. Neurotoxicity produced by intracranial administration of methylmercury in rats Toxicology and Applied Pharmacology. 29: 289-300. PMID 4283694 DOI: 10.1016/0041-008X(74)90066-0 |
0.559 |
|
| Show low-probability matches. |